Back to search

Article

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications

2024-10-07

Abstract excerpt

In 2021, the World Health Organization classified isocitrate dehydrogenase (IDH) mutant gliomas as a distinct subgroup of tumors with genetic changes sufficient to enable a complete diagnosis. Patients with an IDH mutant glioma have improved survival which has been further enhanced by the advent of targeted therapies. IDH enzymes contribute to cellular metabolism, and mutations to specific catalytic residues resul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71b579dd-ff92-5f08-a35a-acc4cc754a4f
DOI
10.20944/preprints202410.0393.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical ImplicationsDOI 10.20944/preprints202410.0393.v1
Select a neighboring publication to make it the new centre.